Schuetz E G, Hazelton G A, Hall J, Watkins P B, Klaassen C D, Guzelian P S
J Biol Chem. 1986 Jun 25;261(18):8270-5.
We have recently proposed that glucocorticoids induce cytochrome P-450p, a liver microsomal hemoprotein originally isolated from rats treated with the antiglucocorticoid pregnenolone 16 alpha-carbonitrile (PCN), through a mechanism that involves a stereospecific recognition system clearly distinguishable from the classic glucocorticoid receptor (Schuetz, E. G., Wrighton, S. A., Barwick, J. L., and Guzelian, P. S. (1984) J. Biol. Chem. 259, 1999-2012). We now report that digitoxigenin monodigitoxoside UDP-glucuronosyltransferase (DIG UDP-glucuronosyltransferase), a liver microsomal enzyme activity induced by PCN in rats, is also inducible, as is P-450p, in primary monolayer cultures of adult rat hepatocytes. DIG UDP-glucuronosyltransferase activity closely resembled reported characteristics of induction of P-450p in its time course of induction, concentration-response relationships, exclusivity of induction by steroids with glucocorticoid properties, unusual rank order of potency of glucocorticoid agonists, unusually high ED50 for induction by glucocorticoids, enhanced induction rather than inhibition by anti-glucocorticoids in the presence of glucocorticoids, and finally, induction by nonsteroidal inducers of P-450p. DIG UDP-glucuronosyltransferase activity was also readily detected in human liver microsomes and was elevated in two patients who had received inducers of P-450p. We conclude that the liver enzymes controlled by the postulated PCN recognition system include not only P-450p but also one or more UDP-glucuronosyltransferases.
我们最近提出,糖皮质激素通过一种机制诱导细胞色素P-450p,这是一种最初从用抗糖皮质激素孕烯醇酮16α-腈(PCN)处理的大鼠中分离出来的肝微粒体血红蛋白,该机制涉及一个与经典糖皮质激素受体明显不同的立体特异性识别系统(舒茨,E.G.,赖特顿,S.A.,巴里克,J.L.,和古泽利安,P.S.(1984年)《生物化学杂志》259,1999 - 2012)。我们现在报告,洋地黄毒苷元单洋地黄毒糖苷UDP-葡萄糖醛酸基转移酶(DIG UDP-葡萄糖醛酸基转移酶),一种在大鼠中由PCN诱导的肝微粒体酶活性,在成年大鼠肝细胞的原代单层培养物中也像P-450p一样是可诱导的。DIG UDP-葡萄糖醛酸基转移酶活性在其诱导的时间进程、浓度-反应关系、具有糖皮质激素特性的类固醇诱导的排他性、糖皮质激素激动剂效力的异常排序、糖皮质激素诱导的异常高ED50、在糖皮质激素存在下抗糖皮质激素增强诱导而非抑制以及最后由P-450p的非甾体诱导剂诱导等方面与报道的P-450p诱导特征非常相似。DIG UDP-葡萄糖醛酸基转移酶活性在人肝微粒体中也很容易检测到,并且在两名接受过P-450p诱导剂治疗的患者中有所升高。我们得出结论,由假定的PCN识别系统控制的肝酶不仅包括P-450p,还包括一种或多种UDP-葡萄糖醛酸基转移酶。